September 22, 2017
Checked In: Emmaus Life Sciences’ Chief Executive Dr. Yutaka Niihara.
Stories this photo appears in:
HEALTH CARE: Approvals, big deal boost sector’s local profile.
L.A.’s biotech sector shows signs of life with drug approvals and an $11.9 billion deal for Kite.